Clinical Trial

Evaluation of Amino Acid Metabolism Changes in Ovarian Cancer

Study acronym: AMINOCANCER
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 20, 2024 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
Ovarian cancer is associated with undernutrition in more than half of all cases. The current management of undernutrition-cachexia in cancer is not specific. It is well recognized that the nutritional support currently offered to cancer patients is not effective in combating cachexia, which progresses inexorably, leading to the patient's death. It is therefore necessary to offer specific and adapted care, in particular by optimizing the quality of nitrogen intake. To achieve this, the investigators first need to define the specific amino acid requirements of cancer patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-01-19.
Status change: Not Yet Recruiting → Recruiting 2024-05-17
Trial Details
NCT Number NCT06216496
Lead Sponsor University Hospital, Grenoble
Conditions Ovarian Cancer
Enrollment 23 participants
Start Date 2024-03-11
Primary Completion 2026-04 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2024-05-20